Empagliflozin: Comprehensive Clinical Monograph for Type 2 Diabetes Management

1. Introduction: What is Empagliflozin? Its Role in Modern Diabetes Care So you’re looking into empagliflozin. Let me tell you straight up—this drug changed how I think about diabetes management. It’s not just another glucose-lowering agent. It’s a SGLT2 inhibitor that’s fundamentally altered the trajectory of cardiovascular and renal outcomes in our patients. Empagliflozin (brand name Jardiance, for those writing prescriptions) belongs to the sodium-glucose cotransporter-2 inhibitor class. It works in the proximal renal tubule, blocking glucose reabsorption and causing glycosuria.